Mark Clein and Ethan Leder are experienced entrepreneurs with a 30-year history of creating cutting-edge businesses in the healthcare industry, producing thousands of jobs and significant value for shareholders. Since co-founding Precision Medicine Group, the company has grown to over 3200 employees around the world, all dedicated to the mission of accelerating development and access to breakthrough treatments to improve the lives of patients in need.

Our board of directors has deep knowledge of the biotech and pharma industry and rich insights on the capabilities required to bring the next generation of novel therapies to market.